| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/06/2002 | CA2432029A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | CA2430192A1 Enzymes having dehalogenase activity and methods of use thereof |
| 09/05/2002 | US20020124273 Protein-protein interactions in neurodegenerative diseases |
| 09/05/2002 | US20020123618 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune, thyroid and grave's disease |
| 09/05/2002 | US20020123617 Novel immunoglobulin superfamily members of APEX-1, APEX-2 and APEX-3 and uses thereof |
| 09/05/2002 | US20020123614 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 09/05/2002 | US20020123481 C-fos induced growth factor (FIGF) and DNA encoding same |
| 09/05/2002 | US20020123463 As diagnostics, biosensors and bioreactors, pharmaceuticals |
| 09/05/2002 | US20020123458 Endostatin protein and fragments thereof |
| 09/05/2002 | US20020123139 Antibodies which bind specifically to activin receptor like kinases |
| 09/05/2002 | US20020123120 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/05/2002 | US20020123119 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides and for treatment and prevention of infections |
| 09/05/2002 | US20020123117 Modulator for use in the diagnosis and treatment of rheumatic diseases, cachexia and eating disorders |
| 09/05/2002 | US20020123114 Polypeptide for use in the diagnosis of cancer of the nervous system |
| 09/05/2002 | US20020123102 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of thyroid defcets |
| 09/05/2002 | US20020123096 Dopamine receptors and genes |
| 09/05/2002 | US20020123091 Composition for use in the diagnosis, prevention and treatment of cardiovascular, endothelial or angiogenic disorders in mammals |
| 09/05/2002 | US20020123070 Immunoglobulin for use in the detection of preferential meats; for use in accurately labeling meats |
| 09/05/2002 | US20020123067 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 09/05/2002 | US20020123057 Screening for nucleotide sequence which code for prefrential antibodies; obtain cells, transform with expression vector coding antibody, express vector, recover antibody and nucleotide sequences expressing antibody |
| 09/05/2002 | US20020123047 dexB |
| 09/05/2002 | US20020123044 Diagnosing cancer in humans; obtain biopsy of human tissue, detect and measure signal from bound polypeptide marker, evaluate humans for cancer |
| 09/05/2002 | US20020123042 Detection of loss of the wild-type hubub1 gene |
| 09/05/2002 | US20020123039 Peptide for use in the prevention and treatment of vial infections |
| 09/05/2002 | US20020123031 Methods of use of compounds which inhibit the stem cell signaling pathway |
| 09/05/2002 | US20020122808 Combination of outer-polysaccharides extracted from Brucella comprises "A" outer-polysaccharide and "M" outer-polysaccharide and "R" protein antigens. |
| 09/05/2002 | US20020122807 Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 09/05/2002 | US20020122804 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 09/05/2002 | US20020122802 Diagnosis and treatment of malignant neoplasms |
| 09/05/2002 | US20020122799 Administering soluble receptor for advanced glycation endproduct (RAGE) in an amount effective to inhibit binding of advanced glycation endproducts to RAGE |
| 09/05/2002 | US20020122798 Compounds for targeting |
| 09/05/2002 | US20020122797 Monoclonal antibodies; hybridoma cell lines that produce such monoclonal antibodies. |
| 09/05/2002 | US20020122796 Method for Inhibiting reperfusion injury using antibodies to P-selectin glycoprotein ligand |
| 09/05/2002 | US20020122795 Compositions containing gangliosides for use in the treatment of skin disorders |
| 09/05/2002 | US20020122794 Antigenic preparation for treatment or prevention of helicobacter infection |
| 09/05/2002 | US20020122791 Antigenic CK-18 compounds for therapy and diagnosis and methods for using same |
| 09/05/2002 | US20020122769 Buffering reagents, chelating agents and stabilizers |
| 09/05/2002 | DE10107676A1 Verfahren zur Erhöhung des Ölgehalts in transgenen Pflanzen und Pflanzensamen A method for increasing the oil content in transgenic plants and plant seeds |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236799A2 Human nucleic acid sequences derived from breast tumor tissue |
| 09/04/2002 | EP1235936A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1235934A2 Screening method for candidate drugs |
| 09/04/2002 | EP1235933A2 Mammalian toxicological response markers |
| 09/04/2002 | EP1235926A2 Acyl glucosaminyl inositol amidase family and methods of use |
| 09/04/2002 | EP1235908A2 Polypeptides and polynucleotides encoding same |
| 09/04/2002 | EP1235907A1 6 human secreted proteins |
| 09/04/2002 | EP1235862A2 A major neutralization site of hepatitis e virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralization antibodies |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235859A1 New olfactory receptor polypeptides and dna sequences thereof |
| 09/04/2002 | EP1235847A2 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
| 09/04/2002 | EP1235846A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235845A2 24 human secreted proteins |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235843A1 26 human secreted proteins |
| 09/04/2002 | EP1235842A1 Rna interference pathway genes as tools for targeted genetic interference |
| 09/04/2002 | EP1235838A1 23 human secreted proteins |
| 09/04/2002 | EP1235837A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235805A2 Immunoassay for neonicotinyl insecticides |
| 09/04/2002 | EP1235592A1 COMBINATION OF COMPOUNDS THAT INHIBIT THE BIOLOGICAL EFFECTS OF TNF-$g(a) AND CD95L IN A MEDICAMENT |
| 09/04/2002 | EP1235587A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases comprising all-d peptides |
| 09/04/2002 | EP0941251B1 Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same |
| 09/04/2002 | EP0904095B1 Chimeric isoprenoid synthases and uses thereof |
| 09/04/2002 | EP0896615B1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator |
| 09/04/2002 | CN1367876A Method for separating cells using immunorosettes |
| 09/04/2002 | CN1367836A CHP polypeptide as ligand of PAK65 |
| 09/04/2002 | CN1367834A Proteins derived from white spot syndrome virus and uses thereof |
| 09/04/2002 | CN1367833A Streptococcus pneumoniae proteins and nucleic acid molecules |
| 09/04/2002 | CN1367830A Cancer associated antigens and uses therefor |
| 09/04/2002 | CN1367829A Compositions and methods for therapy and diagnosis of lung cancer |
| 09/04/2002 | CN1367790A Moraxella cattarrhalis BASB114 polypeptide antigens and uses thereof |
| 09/04/2002 | CN1367247A Heavy metal toxinicide, its preparation method and application |
| 09/04/2002 | CN1367180A Novel natural antibacterial peptide, its code sequence and application |
| 09/04/2002 | CN1367179A Novel liver regeneration related protein, its code sequence and application |
| 09/04/2002 | CA2445692A1 Compositions, methods and systems for the discovery of enediyne natural products |
| 09/04/2002 | CA2444812A1 Compositions, methods and systems for the discovery of enediyne natural products |
| 09/04/2002 | CA2444802A1 Compositions, methods and systems for the discovery of enediyne natural products |
| 09/03/2002 | US6444803 Bone mineralization proteins, DNA, vectors, expression systems |
| 09/03/2002 | US6444802 Human aminopeptidase |
| 09/03/2002 | US6444790 Peptidoglycan recognition proteins |
| 09/03/2002 | US6444787 Vaccines |
| 09/03/2002 | US6444468 Treating a sample comprising different double-stranded template polynucleotides wherein said different template polynucleotides contain areas of identity and areas of heterology under conditions which provide for the cleavage of |
| 09/03/2002 | US6444446 Calcium binding proteolipid compositions and methods |
| 09/03/2002 | US6444443 Gene |
| 09/03/2002 | US6444439 Cloning and characterization of a cdc15-like adaptor protein (CD2BP1) |
| 09/03/2002 | US6444431 Angiostatin receptor |
| 09/03/2002 | US6444208 Ribonuclease III from Streptococcus pneumoniae |
| 09/03/2002 | US6444207 Binding with epitope of antigen; anticancer agents |
| 09/03/2002 | US6444206 Sepsis therapy; monoclonal antibodies |
| 09/03/2002 | CA2160764C Fish pancreatic disease virus |
| 09/03/2002 | CA2049089C Immunoassay reagents and method for determining cyclosporine |
| 09/03/2002 | CA2001815C Products and methods for controlling the suppression of the neoplastic phenotype |
| 08/29/2002 | WO2002066980A1 Methods for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes |
| 08/29/2002 | WO2002066659A1 Method for increasing the oil content in transgenic plants and plant seed |
| 08/29/2002 | WO2002066649A2 ANTI-INTERFERON-α ANTIBODIES |
| 08/29/2002 | WO2002066648A2 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066641A1 Pg-3 and biallelic markers thereof |
| 08/29/2002 | WO2002066636A2 T cell receptor variants expressed in mesenchymal cells and uses thereof |
| 08/29/2002 | WO2002066631A1 Antibodies recognizing helicobacter pylori and method of detecting helicobacter pylori |